SE0303417D0 - Screen - Google Patents

Screen

Info

Publication number
SE0303417D0
SE0303417D0 SE0303417A SE0303417A SE0303417D0 SE 0303417 D0 SE0303417 D0 SE 0303417D0 SE 0303417 A SE0303417 A SE 0303417A SE 0303417 A SE0303417 A SE 0303417A SE 0303417 D0 SE0303417 D0 SE 0303417D0
Authority
SE
Sweden
Prior art keywords
agent
fibrinolysis
amount
degradation products
fibrin degradation
Prior art date
Application number
SE0303417A
Other languages
English (en)
Swedish (sv)
Inventor
Petter Bjoerquist
Viveca Nerme
Karin Waahlander
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0303417A priority Critical patent/SE0303417D0/xx
Publication of SE0303417D0 publication Critical patent/SE0303417D0/xx
Priority to PCT/GB2004/005249 priority patent/WO2005059170A2/fr

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
SE0303417A 2003-12-17 2003-12-17 Screen SE0303417D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0303417A SE0303417D0 (sv) 2003-12-17 2003-12-17 Screen
PCT/GB2004/005249 WO2005059170A2 (fr) 2003-12-17 2004-12-14 Crible

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303417A SE0303417D0 (sv) 2003-12-17 2003-12-17 Screen

Publications (1)

Publication Number Publication Date
SE0303417D0 true SE0303417D0 (sv) 2003-12-17

Family

ID=30439730

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303417A SE0303417D0 (sv) 2003-12-17 2003-12-17 Screen

Country Status (2)

Country Link
SE (1) SE0303417D0 (fr)
WO (1) WO2005059170A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082340A1 (fr) * 2007-12-20 2009-07-02 Astrazeneca Ab Procédé de suivi de la progression de la fibrinolyse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3900493A1 (de) * 1989-01-10 1990-07-12 Thomae Gmbh Dr K Verfahren zur bestimmung der fibrinolytischen gesamtaktivitaet im plasma
US6472161B1 (en) * 1992-10-15 2002-10-29 Robert F. Baugh Method of evaluating blood clot lysis condition

Also Published As

Publication number Publication date
WO2005059170A3 (fr) 2005-08-11
WO2005059170A2 (fr) 2005-06-30

Similar Documents

Publication Publication Date Title
ATE431427T1 (de) Verbessertes verfahren zum nachweis von atp
ATE205884T1 (de) Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie
DE69424663D1 (de) Reporterenzym-freisetzungstechnologie: verfahren zum nachweis der gegenwart von aspartat-proteasen und anderen aktivitaeten von hydrolytischen enzymen
ATE465415T1 (de) Protokoll zur bestimmung von heparininduzierter thrombozytopenie
ATE466098T1 (de) Kinase- und phosphatasetests
ATE544071T1 (de) Fluoreszenzpolarisationstests für die acetyltransferase-deacetylase-aktivität
ATE443775T1 (de) Hif-prolylhydroxylase-aktivitätstest
WO2000046602A3 (fr) Procede permettant de determiner la concentration d'inhibiteurs de thrombine
HRP20060118A2 (en) Method and device for the detection of very small quantities of particles
EP1221620A3 (fr) Méthode pour effectuer la mesure du "activated clotting time" ayant une sensibilité réduite envers la présence de l'aprotinine ainsi que pour évaluer la sensibilité vis-à-vis de l'aprotinine
DE60029413D1 (de) Enzymatische messung von mycophenolsäure
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
ATE502303T1 (de) Reagens und kit zur bestimmung der globalen gerinnungsfähigkeit und des hämostatischen potentials
ATE503021T1 (de) Verfahren zum nachweis von endoglykosidase aktivität
GB0420774D0 (en) Wound treatment system
SE0303417D0 (sv) Screen
ATE288587T1 (de) Verfahren zur bestimmung der lipid-aufnahme
ATE449380T1 (de) System und verfahren zur quantitativen anwendungsmessung
HUP0500620A2 (hu) Oldható fibrin vizsgálatára szolgáló eljárás
WO2002038799A3 (fr) Detection de proteases et criblage d'inhibiteurs de proteases
ATE438100T1 (de) Verfahren zum funktionellen nachweis von masps und dessen komplexen
DE502005011186D1 (de) Stabiles, chromogenes Testreagenz und dessen Verwendung in gerinnungsdiagnostischen Tests
ATE288081T1 (de) Verfahren zum selektieren von inhibitoren für enzyme
ATE373723T1 (de) Verbessertes verfahren zum nachweis von proteolytischen enzymen
ATE339683T1 (de) Verfahren zur detektion und konzentrationsbestimmung von schwefelfreien odoriermitteln in erd- oder brenngas